- Home
- ATXG vs EVOK Comparison
ATXG vs EVOK Comparison
Compare ATXG & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- EVOK
- Stock Information
- Founded
- ATXG 2014
- EVOK 2007
- Country
- ATXG China
- EVOK United States
- Employees
- ATXG N/A
- EVOK N/A
- Industry
- ATXG Professional Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- EVOK Health Care
- Exchange
- ATXG Nasdaq
- EVOK Nasdaq
- Market Cap
- ATXG 3.8M
- EVOK 4.2M
- IPO Year
- ATXG N/A
- EVOK 2013
- Fundamental
- Price
- ATXG $0.75
- EVOK $3.23
- Analyst Decision
- ATXG
- EVOK
- Analyst Count
- ATXG 0
- EVOK 0
- Target Price
- ATXG N/A
- EVOK N/A
- AVG Volume (30 Days)
- ATXG 18.5K
- EVOK 14.9K
- Earning Date
- ATXG 02-14-2025
- EVOK 05-13-2025
- Dividend Yield
- ATXG N/A
- EVOK N/A
- EPS Growth
- ATXG N/A
- EVOK N/A
- EPS
- ATXG N/A
- EVOK N/A
- Revenue
- ATXG $4,549,310.00
- EVOK $10,249,415.00
- Revenue This Year
- ATXG N/A
- EVOK $58.84
- Revenue Next Year
- ATXG N/A
- EVOK $58.11
- P/E Ratio
- ATXG N/A
- EVOK N/A
- Revenue Growth
- ATXG N/A
- EVOK 97.84
- 52 Week Low
- ATXG $0.49
- EVOK $1.94
- 52 Week High
- ATXG $1.18
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ATXG 50.89
- EVOK 63.38
- Support Level
- ATXG $0.69
- EVOK $3.00
- Resistance Level
- ATXG $0.89
- EVOK $3.36
- Average True Range (ATR)
- ATXG 0.10
- EVOK 0.25
- MACD
- ATXG 0.01
- EVOK 0.13
- Stochastic Oscillator
- ATXG 33.94
- EVOK 89.46
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.